10-Q: National Vision Posts Strong Q2 Growth, Repays Debt
Quarterly Report
National Vision Holdings, Inc. reported significant revenue and profit growth for the second quarter and first half of fiscal 2025, driven by strong comparable store sales and new store openings, alongside the full repayment of its 2025 convertible senior notes.
Summary
- Total net revenue for the six months ended June 28, 2025, increased by $62.2 million, or 6.7%, to $996.7 million, compared to $934.5 million for the same period in 2024.
- Net income from continuing operations for the six months ended June 28, 2025, was $22.911 million, a significant increase from $10.712 million in the prior year period.
- Diluted earnings per share from continuing operations for the six months ended June 28, 2025, rose to $0.29, up from $0.14 in the comparable period of 2024.
- Adjusted EBITDA from continuing operations increased by 18.4% to $110.237 million for the six months ended June 28, 2025, compared to $93.117 million in the prior year.
- Adjusted Comparable Store Sales Growth from continuing operations was 5.7% for the six months ended June 28, 2025, reflecting a higher average ticket, a slight increase in customer traffic, and continued strength in the managed care cohort.
- The company fully repaid its $84.8 million outstanding principal balance of 2.50% convertible senior notes due May 15, 2025, for $85.8 million, inclusive of accrued interest.
- As of June 28, 2025, the company operated 1,240 retail optical locations, a net increase of 24 stores from June 29, 2024.
Sentiment
Score: 8
Explanation: The company delivered strong financial results with significant revenue growth, a substantial increase in net income, and improved profitability margins. The successful repayment of a major debt obligation further strengthens its financial health. While macroeconomic and operational challenges persist, the company's strategic initiatives and positive performance trends indicate strong momentum.
Positives
- Total net revenue increased by 6.7% for the six months ended June 28, 2025, demonstrating strong top-line growth.
- Net income from continuing operations surged by 113.9% to $22.911 million for the first half of fiscal 2025, indicating improved profitability.
- Adjusted EBITDA from continuing operations grew by 18.4% to $110.237 million, with Adjusted EBITDA Margin improving to 11.1% from 10.0% in the prior year, reflecting operational efficiency gains.
- Adjusted Comparable Store Sales Growth of 5.7% indicates healthy organic growth driven by higher average ticket and managed care strength.
- Successful repayment of $84.8 million in convertible senior notes significantly reduces near-term debt obligations and strengthens the balance sheet.
- Net cash provided by operating activities increased by $11.1 million to $86.5 million for the six months ended June 28, 2025, reflecting improved cash generation from core operations.
- Asset impairment charges decreased significantly to $0.5 million for the six months ended June 28, 2025, from $4.0 million in the prior year, suggesting fewer underperforming stores.
Negatives
- Cash and cash equivalents decreased to $48.471 million as of June 28, 2025, from $73.948 million at December 28, 2024, primarily due to debt repayment.
- Net cash used for financing activities increased significantly to $78.825 million for the six months ended June 28, 2025, compared to $7.440 million in the prior year, largely due to the debt repayment.
- Interest expense, net, increased to $8.8 million for the six months ended June 28, 2025, from $7.5 million in the prior year, primarily due to lower interest income on cash balances.
Risks
- Overall decline in the health of the economy, global macroeconomic conditions, and other factors that may affect consumer spending or behavior.
- Ability to successfully implement transformation initiatives or anticipate the impact of important strategic initiatives.
- Ability to recruit and retain vision care professionals for in-store roles or to provide remote care offerings, leading to increased costs and exam capacity constraints.
- Highly competitive optical retail industry.
- Changes in the cost of inputs, including wage rate increases, inflation, and increases in raw materials and energy prices.
- Significant capital requirements to fund expanding business, including updating Enterprise Resource Planning (ERP) and Customer Relationship Management (CRM) systems.
- Potential for growth strategy to strain existing resources and cause the performance of existing stores to suffer.
- Impacts resulting from the termination of the partnership with Walmart.
- Potential for certain technological advances, greater availability of, or increased consumer preferences for, vision correction alternatives to prescription eyeglasses or contact lenses, or future drug development for the correction of vision-related problems to reduce demand for products.
- Impact of any significant failure, inadequacy, interruption, or security breach affecting information technology systems, or those of vendors.
- Outcome of legal proceedings relating to business operations, including ongoing class action and derivative lawsuits.
- Risks related to indebtedness and changes in interest rates.
Future Outlook
The company plans to open approximately 32 new stores in fiscal year 2025, continuing to invest capital in existing operations to enhance the overall store experience. Management remains focused on expanding its target demographic, implementing new pricing architecture, enhancing the customer and patient experience, and optimizing cost structure to strengthen the core business and drive long-term shareholder value. The company is evaluating the impact of the recently enacted One Big Beautiful Bill Act (OBBBA) but does not currently expect it to materially impact the effective tax rate in the current fiscal year.
Management Comments
- We continue to focus on expanding our target demographic, implementing new pricing architecture, enhancing the customer and patient experience, and optimizing cost structure, which are initiatives designed to strengthen our core business, improve our results of operations, and drive long-term shareholder value.
- We plan to open approximately 32 new stores in fiscal year 2025 to allow us to invest capital in existing operations to enhance the overall store experience.
- We are continuing to monitor and determine our plans for future new store openings at a level appropriate for incremental free cash flow generation.
Industry Context
The company operates as a leading value retailer in the highly competitive U.S. optical retail industry. It faces ongoing challenges related to recruiting and retaining vision care professionals, with demand for optometrists exceeding supply in certain areas, leading to increased costs. Macroeconomic factors such as inflation, wage rate pressures, and tariffs continue to impact costs, though the company notes less than 10% of its costs are directly subject to China tariffs and less than 1% to Mexico tariffs. The business experiences seasonality, with a higher portion of revenue and income in the first half of the year, influenced by tax refunds and health insurance resets.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | L. Reade Fahs | Alex Wilkes | 2025-08-01 | CEO succession plan, transition to Executive Chair role. |
| Executive Chair of the Board | NA | L. Reade Fahs | 2025-08-01 | Transition from CEO to support new CEO and provide industry experience. |
Legal Proceedings
- A California wage and hour class action lawsuit was settled for a gross fund of $4.5 million. Preliminary approval was granted on March 21, 2025, and final approval on July 25, 2025, with payment expected by October 7, 2025.
- A related California Private Attorneys General Act (PAGA) action saw the plaintiff accept a $60,000 offer of compromise on April 17, 2025, leading to the arbitrator closing the file on June 4, 2025.
- A Securities Class Action lawsuit in the Northern District of Georgia was dismissed with prejudice on March 30, 2024, and a motion for reconsideration was denied on March 24, 2025, with no appeal filed.
- A Stockholder Derivative Action in the Delaware Court of Chancery, based on similar allegations as the Securities Class Action, is ongoing, with a motion to dismiss the amended complaint filed on October 31, 2024, and oral argument cancelled without rescheduling.
Stakeholder Impact
- Shareholders: Positive financial results, including increased net income and EPS, and debt reduction, are likely to be viewed favorably, potentially supporting share price.
- Employees: Severance benefits were recognized for certain associates, and the company continues to face challenges in recruiting and retaining vision care professionals, which could impact staffing and operational costs.
- Customers: Strategic initiatives focus on enhancing customer and patient experience and optimizing pricing, aiming to deliver continued value and service.
- Creditors: The full repayment of the 2025 convertible senior notes demonstrates strong financial management and adherence to debt covenants, positively impacting creditor confidence.
Next Steps
- Open approximately 32 new stores in fiscal year 2025.
- Continue to implement transformation initiatives, including new pricing architecture, enhanced customer and patient experience, and cost structure optimization.
- Evaluate the impact of the One Big Beautiful Bill Act (OBBBA) on financial position and effective tax rate.
- L. Reade Fahs will transition to Executive Chair of the Board effective August 1, 2025.
Key Dates
| Date | Description |
|---|---|
| 2024-03-11 | Mediation for California wage and hour class action lawsuit. |
| 2024-03-24 | Court denied motion for reconsideration in the Securities Class Action lawsuit. |
| 2024-04-17 | Company served a Section 998 offer of compromise for $60,000 in a California PAGA action, which was accepted by the plaintiff. |
| 2024-05-15 | Maturity date of 2.50% convertible senior notes, which were fully repaid. |
| 2024-06-04 | Arbitrator closed file on the California PAGA action after the offer of compromise was accepted. |
| 2024-06-20 | Oral argument on motion to dismiss in the Stockholder Derivative Action was scheduled, then cancelled. |
| 2024-06-28 | End of the current quarterly period for the 10-Q filing. |
| 2024-07-04 | One Big Beautiful Bill Act (OBBBA) was enacted. |
| 2024-07-25 | Court issued final approval of the $4.5 million settlement for the California wage and hour class action lawsuit. |
| 2024-08-01 | L. Reade Fahs' transition date from Chief Executive Officer to Executive Chair of the Board. |
| 2024-08-07 | Date of filing of the 10-Q report. |
| 2024-08-28 | Start date for L. Reade Fahs' Rule 10b5-1 Trading Plan. |
| 2024-10-07 | Deadline for the company to issue payment for the $4.5 million legal settlement. |
| 2025-01-03 | End of fiscal year 2025 (53 weeks). |
| 2026-04-30 | End date for L. Reade Fahs' Rule 10b5-1 Trading Plan. |
| 2027 | End of Initial Term for L. Reade Fahs' Executive Chair Agreement (annual meeting of stockholders). |
Recommendation
buyThe company's strong financial performance, marked by significant revenue growth, a substantial increase in net income, and improved Adjusted EBITDA margins, indicates robust operational health. The successful repayment of a major debt obligation further strengthens the balance sheet and reduces financial risk. Strategic initiatives focused on growth and efficiency, coupled with positive comparable store sales, suggest continued positive momentum. Despite ongoing industry challenges like labor availability and macroeconomic pressures, the company's results demonstrate effective management and a strong market position, making it an attractive investment.
Keywords
optical retail, eyewear, contact lenses, vision care, Americas Best, Eyeglass World, SEC filing, 10-Q, financial results, debt repayment, store expansion
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.